Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
People may have been exposed to online advertisements for oral tirzepatide near them, but these compounded versions are not verified for safety or efficacy
The medication has been shown to improve other cardiovascular risk factors, such as lowering blood pressure and improving lipid profiles, thereby further mitigating potential heart-related issues
Safety Signals in Phase II While efficacy was impressive, the trials also raised important safety concerns: Heart rate increases: Mean increases of 7.4 bpm (0.5 mg) and 9.1 bpm (1.0 mg) versus placebo Blood pressure: Modest systolic increases at higher doses Psychiatric effects: Insomnia (2135%), dry mouth (3044%), and mood changes in some patients Gastrointestinal: Nausea, diarrhea, and constipation at rates above placebo The cardiovascular signal particularly the heart rate increase would become the central obstacle in tesofensine's regulatory path
Keeping chloride levels balanced alongside other electrolytes helps support a more complete and effective hydration routine
Constipation management guidelines
